Innate immune properties of selected human neuropeptides against Moraxella catarrhalis and nontypeable Haemophilus influenzae

BMC Immunology

Zuzanna Drulis-Kawa³  Jan Gutowicz⁴  Agnieszka Skowyra³  Paweł Mackiewicz¹  Adam Jankowski²  Daria Augustyniak³ 

[1] Department of Genomics, Faculty of Biotechnology, University of Wroclaw, Przybyszewskiego 63/77, 51-148, Wroclaw, Poland;Department and Clinics of Pediatrics, Immunology and Rheumatology of Developmental Age, Medical University of Wroclaw, Kasprowicza 64/66, 51-137, Wroclaw, Poland;Department of Pathogen Biology and Immunology, Institute of Genetics and Microbiology, University of Wroclaw, Przybyszewskiego 63/77, 51-148, Wroclaw, Poland;Depertment of Physico-Chemistry of Microorganisms, Institute of Genetics and Microbiology, University of Wroclaw, Przybyszewskiego 63/77, 51-148, Wroclaw, Poland

关键词: Haemophilus influenzae;    Moraxella catarrhalis;    Immunomodulation;    Phagocytosis;    Permeabilization;    Killing;    Somatostatin;    CGRP;    Substance P;    Neuropeptide Y;   

Others  :  1077918
DOI  :  10.1186/1471-2172-13-24

 received in 2011-10-21, accepted in 2012-04-14,  发布年份 2012

【 摘 要 】

Background

Considerable evidence supports the concept of active communication between the nervous and immune systems. One class of such communicators are the neuropeptides (NPs). Recent reports have highlighted the antimicrobial activity of neuropeptides, placing them among the integral components of innate immune defense. This study examined the action of four human neuropeptides: calcitonin gene-related peptide (CGRP), neuropeptide Y (NPY), substance P (SP) and somatostatin (SOM), which are accessible in the upper respiratory tract, against two human-specific respiratory pathogens. We studied: (i) neuropeptide-mediated direct antibacterial activity exerted against Moraxella catarrhalis and nontypeable Haemophilus influenzae, and (ii) indirect immunomodulatory role of these neuropeptides in the neutrophil-mediated phagocytosis of indicated pathogens.

Results

We found that 100 micromolar concentrations of CGRP, NPY, SP, and SOM effectively permeabilized bacterial membranes and showed (except SOM) bactericidal activity against both pathogens. SOM acted only bacteriostatically. However the killing efficacy was dependent on the bactericidal assay used. The rank order of killing NP effect was: NPY ≥ CGRP > SP >> SOM and correlated with their potency to permeabilize bacterial membranes. The killing and permeabilization activity of the analyzed NPs showed significant correlation with several physicochemical properties and amino acid composition of the neuropeptides. M. catarrhalis was more sensitive to neuropeptides than nontypeable H. influenzae.

The immunomodulatory bimodal effect of physiological concentrations of CGRP, NPY, and SP on the phagocytic function of human neutrophils against M. catarrhalis and H. influenzae was observed both in the ingestion (pathogen uptake) and reactive oxygen species generation stages. This effect was also dependent on the distinct type of pathogen recognition (opsonic versus nonopsonic).

Conclusions

The present results indicate that neuropeptides such as CGRP, NPY, and SP can effectively participate in the direct and indirect elimination of human-specific respiratory pathogens. Because the studied NPs show both direct and indirect modulating antimicrobial potency, they seem to be important molecules involved in the innate host defense against M. catarrhalis and nontypeable H. influenzae.

【 授权许可】

   
2012 Augustyniak et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1 .

Figure 2 .

Figure 3 .

Figure 4 .

Figure 5 .

【 参考文献 】

• [1]Sternberg EM: Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006, 6:318-328.
• [2]Brogden KA, Guthmiller JM, Salzet M, Zasloff M: The nervous system and innate immunity: the neuropeptide connection. Nat Immunol 2005, 6:558-563.
• [3]Levite M: Neuropeptides by direct interaction with T cells induce cytokine secretion and break the commitment to a distinct T helper phenotype. PNAS 1998, 95:12544-12549.
• [4]Cuesta MC, Quintero L, Pons H, Suarez-Roca H: Substance P and calcitonin gene-related peptide increase IL-1β, IL-6 and TNF-α secretion from human peripheral blood mononuclear cells. Neurochem Int 2002, 40:301-306.
• [5]Ding W, Stohl LL, Wagner JA, Granstein RD: Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity. J Immunol 2008, 181:6020-6026.
• [6]Dunzendorfer S, Kaser A, Meierhofer C, Tilg H, Wiedermann CJ: Peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J Immunol 2001, 166:2167-2172.
• [7]Ahmed AA, Wahbi AH, Nordlin K: Neuropeptides modulate a murine monocyte/macrophage cell line capacity for phagocytosis and killing of Leishmania major parasites. Immunopharmacol Immnotoxicol 2001, 23:397-409.
• [8]Bedoui S, Kromer A, Gebhardt T, Jacobs R, Raber K, Dimitrijevic M, Heine J, von Hörsten S: Neuropeptide Y receptor-specifically modulates human neutrophil function. J Neuroimmunol 2008, 195:88-95.
• [9]Delgado M, Ganea D: Anti-inflammatory neuropeptides: A new class of endogenous immunoregulatory agents. Brain Behavior and Immunity 2008, 22:1146-1151.
• [10]Elenkov IJ, Wilder RL, Chousos GP, Vizi ES: The sympathetic nerve – an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000, 52:595-638.
• [11]Chanez P, Springall D, Vignola AM, Moradoghi-Hattvani A, Polak JM, Godard P, Bousquet J: Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases. Am J Respir Crit Care Med 1998, 158:985-990.
• [12]Hellström S, Goldie P: Mechanisms ofotitis mediadevelopment. Involvement of neurogenic inflammation. Otolaryngol Clin North Am 1991, 24:829-834.
• [13]Hauser-Kronenberg C, Hacker GW, Muss W, Saria A, Albegger K: Autonomic and peptidergic innervations of human nasal mucosa. Acta Otolaryngol Stockh 1993, 113:387-393.
• [14]Figueroa JM, Mansilla E, Suburo AM: Innervation of nasal turbinate blood vessels in rhinitic and nonrhinitic children. Am J Respir Crit Care Med 1998, 157:1959-1966.
• [15]Basak S, Dikicioglu E, Turkutanit S, Sarierler M: Early and late effects of capsaicin pretreatment inotitis mediawith effusion. Otol Neurotol 2005, 26:344-350.
• [16]Belvisi MG: Overview of the innervations of the lung. Curr Opin Pharmacol 2002, 2:211-215.
• [17]Schwarz H, Vilinger PM, von Kempis J, Lotz M: Neuropeptide Y is an inducible gene in the human immune system. J Neuroimmunol 1994, 51:53-61.
• [18]Ho W-Z, Lai J-P, Zhu X-H, Uvaydova M, Douglas SD: Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 1997, 159:5654-5660.
• [19]Wang H, Xing L, Li W, Hou L, Guo J, Wang X: Production and secretion of calcitonin gene-related peptide from human lymphocytes. J Neuroimmunol 2002, 130:155-162.
• [20]Brogden KA: Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005, 3:238-250.
• [21]Kowalska K, Carr DB, Lipkowski AW: Direct antimicrobial properties of substance P. Life Sci 2002, 71:747-750.
• [22]Hansen CJ, Burnell KK, Brogden KA: Antimicrobial activity of substance P and neuropeptide Y against laboratory strains of bacteria and oral microorganisms. J Neuroimmunol 2006, 177:215-218.
• [23]El Karim IA, Linden GJ, Orr DF, Lundy FT: Antimicrobial activity of neuropeptides against a range of microorganisms from skin, oral, respiratory and gastrointestinal tract sites. J Neuroimmunol 2008, 200:11-16.
• [24]De Vries SP, Bootsma HJ, Hays JP, Hermans PW: Molecular aspects of Moraxella catarrhalis pathogenesis. Microbiol Mol Biol Rev 2009, 73:389-406.
• [25]Nizet V, Colina KF, Almquist JR, Rubens CE, Smith AL: A virulent nonencapsulated Haemophilus influenza. J Infect Dis 1996, 173:180-186.
• [26]Murphy TF, Bakaletz LO, Smeesters PR: Microbial interactions in the respiratory tract. Pediatr Infect Dis 2009, 28(10 suppl):S121-S126.
• [27]Murphy TF, Brauer AL, Grant BJ, Sethi S: Moraxella catarrhalisin chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med 2005, 172:195-199.
• [28]Moghaddam SJ, Clement CG, De la Garza MM, Zou X, Travis EL, Young HW, Evans CM, Tuvim MJ, Dickey BF: Haemophilus influenzaelysate induces aspects of the chronic obstructive pulmonary disease phenotype. Am J Respire Cell Mol Biol 2008, 38:629-638.
• [29]Mukundan D, Ecevit Z, Patel M, Mars CF, Gilsdorf JR: Pharyngeal colonization dynamics ofHaemophilus influenzaeandHaemophilus haemolyticusin healthy adult carriers. J Clin Microbiol 2007, 45:3207-3217.
• [30]Heiniger N, Spaniol V, Troller R, Vischer M, Aebi C: A reservoir ofMoraxella catarrhalisin human pharyngeal lymphoid tissue. J Infect Dis 2007, 196:1080-1087.
• [31]Billal DS, Hotomi M, Suzumoto M, Yamauchi K, Kobayashi I, Fujihara K, Yamanaka N: Rapid identification of nontypeable and serotype bHaemophilus influenzaefrom nasopharyngeal secretions by the multiplex PCR. Int J Pediatr Otorhinolaryngol 2007, 71:269-274.
• [32]Lehrer RI, Rosenman M, Harwiq SS, Jackson S, Eisenhauer P: Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 1991, 137:167-173.
• [33]Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J: The structure of human macrophage inflammatory protein-3α/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human β-defensins. J Biol Chem 2002, 277:37647-37654.
• [34]Lehrer RJ, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME: Interaction of human defensins withEscherichia coli. Mechanism of bactericidal activity. J Clin Invest 1989, 84:553-561.
• [35]Starner TD, Barker CK, Jia HP, Kang Y, McCray PB Jr: CCL20 is an inducible product of human airway epithelia with innate immune properties. Am J Respir Cell Mol Biol 2002, 29:627-633.
• [36]Lamprou I, Mamali I, Dallas K, Fertakis V, Lampropoulou M, Marmaras VJ: Distinct signaling pathways promote phagocytosis of bacteria, latex beads and lipoppolysaccharide in medfly haemocytes. Immunology 2007, 121:314-327.
• [37]Tecle T, White MR, Gantz D, Crouch EC, Hartshorn KL: Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. J Immunol 2007, 178:8046-8052.
• [38]Allen RC: Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol 1986, 133:449-493.
• [39]Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A: Protein Identification and Analysis Tools on the ExPASy Server. In The Proteomics Protocols Handbook. Volume 112. 2005, 531-552.
• [40]Grantham R: Amino acid difference formula to help explain protein evolution. Science 1974, 185:862-864.
• [41]Kyte J, Doolittle RF: A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982, 157:105-132.
• [42]Zhao G, London E: An amino acid “transmembrane tendency” scale that approaches the theoretical limit to accuracy for prediction of transmembrane helices: relationship to biological hydrophobicity. Protein Sci 2006, 15:1987-2006.
• [43]Deleage G, Roux B: An algorithm for protein secondary structure prediction based on class prediction. Protein Engineering 1987, 1:289-294.
• [44]Rice P, Longden I, Bleasby A: EMBOSS: The European Molecular Biology Open Software Suite. Trends Genet 2000, 16:276-277.
• [45]Dathe M, Wieprecht T: Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim Biophys Acta 1999, 1462:71-87.
• [46]Ichinose M, Sawada M: Enhancement of phagocytosis by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages. Peptides 1996, 17:1405-1414.
• [47]Powers J-PS, Hancock REW: The relationship between peptide structure and antibacterial activity. Peptides 2003, 24:1681-1691.
• [48]Sánchez-Gómez S, Lamata M, Leiva J, Blondelle SE, Jerala R, Andrä J, Brandenburg K, Lohner K, Moriyón I, Martínez-de-Tejada G: Comparative analysis of selected methods for the assessment of antimicrobial and membrane-permeabilizing activity: a case study for lactoferricin derived peptides. BMC Microbiol 2008, 8:1-9. BioMed Central Full Text
• [49]Dakhama A, Park J-W, Taube Ch, El Gazzar M, Kodama T, Miyahara N, Takeda K, Kanehiro A, Balhorn A, Joetham A, Loader JE, Larsen G, Gelfand EW: Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol 2005, 288:L761-L770.
• [50]Chu HW, Kraft M, Krause JE, Rex MD, Martin RJ: Substance P and its receptor neurokinin 1 expression in asthmatic airways. J Allergy Clin Immunol 2000, 106:713-722.
• [51]Killough SA, Lundy FT, Irwin CR: Substance P expression by human dental pulp fibroblasts: a potential role in neurogenic inflammation. J Endod 2009, 35:73-77.
• [52]Giacometti A, Cirioni O, Barchiesi F, Fortuna M, Scalise G: In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents againstPseudomonas aeruginosa. J Antimicrob Chemother 1999, 44:641-645.
• [53]Joly S, Maze C, McCray PB, Guthmiller JM: Human β-defensisn 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 2004, 42:1024-1029.
• [54]Schelburne CE, Coulter WA, Olguin D, Lantz MS, Lopatin DE: Induction of β-defensisn resistance in the oral anaerobePorphyromonas gingivalis. Antimicrob Agents Chemother 2005, 49:183-187.
• [55]Iovine NM, Elsbach P, Weiss J: An opsonic function of the neutrophil bactericidal/permeability increasing protein depends on both its N- and C-terminal domains. Proc Natl Acad Sci 1997, 94:10973-10978.
• [56]Zughaier SM, Shafer WM, Stephens DS: Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell Microbiol 2005, 7:1251-1262.
• [57]Gallicchio M, Benetti E, Rosa AC, Fantozzi R: Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes. British J Pharmacol 2009, 156:486-496.
• [58]Schmitter T, Agerer F, Peterson L, Munzner P, Hauck CR: Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human-specific pathogens. J Exp Med 2004, 199:35-46.
• [59]Underhill DM, Ozinsky A: Phagocytosis of microbes: complexity in action. Ann Rev Immunol 2002, 20:825-852.
• [60]Garcia-Garcia E, Rosales C: Signal transduction during Fc receptor-mediated phagocytosis. J Leuk Biol 2002, 72:1092-1108.
• [61]Harzenetter MD, Keller U, Beer S, Riedl C, Peschel Ch, Holzmann B: Regulation and function of the CGRP receptor complex in human granulopoiesis. Exp Hematol 2002, 30:306-312.
• [62]Richter J, Andersson R, Edvinsson L, Gullberg U: Calcitonin gene-related peptide (CGRP) activates human neutrophils – inhibition by chemotactic peptide antagonist BOC-MLP. Immunology 1992, 77:416-421.
• [63]Ganea D, Delgado M: Neuropeptides as modulators of macrophage functions. Regulations of cytokine production and antigen presentation by VIP and PACAP. Arch Immun Ther Exp 2001, 49:101-110.
• [64]Kaneider NC, Egger P, Djanani AM, Wiedermann ChJ: Leukocyte motility in response to neuropeptides is heperan sulfate proteoglycan dependent. Peptides 2003, 24:695-700.
• [65]Medina S, Del Rio M, Hernanz A, De la Fuente M: The NPY effects on murine leukocyte adherence and chemotaxis change with age. Adherent cell implication. Regul Pept 2000, 95:35-45.
• [66]Janiszewski J, Bienenstock J, Blennerhassett MG: Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am J Physiol Cell Physiol 1994, 267:138-145.
• [67]Bedoui S, Kawamura N, Straub RH, Pabst R, Yamamura T, von Horsten S: Relevance of neuropeptide Y fo the neuroimmune crosstalk. J Neuroimmunol 2003, 134:1-11.
• [68]Braun A, Wiebe P, Pfeufer A, Geβner R, Renz H: Different modulation of human immunoglobulin isotype production by the neuropeptides substance P, NKA, and NKB. J Neuroimmunol 1999, 97:43-50.
• [69]Levite M, Cahalon L, Herskoviz R, Steinman L, Lider O: Neuropeptides, via specific receptors, regulate T cell adhesion to fibronectin. J Immunol 1998, 160:993-1000.
• [70]Kuo H-P, Lin H-Ch, Hwang K-H, Wang Ch-H LuL-Ch: Lipopolysaccharide enhances substance P-mediated neutrophil adherence to epithelial cells and cytokine release. Am J Respir Crit Care Med 2000, 162:1891-1897.
• [71]Lee H-Y, Andalibi A, Webster P, Moon S-K, Teufert K, Kang S-H, Li J-D, Nagura M, Ganz T, Lim DJ: Antimicrobial activity of innate immune molecules againstStreptococcus pneumonia,Moraxella catarrhalisand nontypeableHaemophilus influenzae. BMC Infect Dis 2004, 4:1-12. BioMed Central Full Text